After The Bell

Seattle Genetics Inc. (SGEN) Is Declining After Q2 Loss

Seattle Genetics Inc. (SGEN) reported a second quarter net loss of $0.15 per share after the close Wednesday, compared to the loss of $0.45 per share last year. The consensus estimate was for a loss of $0.15. The stock is now down 1.85 on 8K shares.

Seattle Genetics declined until mid-morning Wednesday and finished down by 0.47 at $23.87. The stock has been pulling back from the highs of the year for the last week and a half and set nearly a 2-month low.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More After The Bell